RxDoctor Payments Data

Michael Banuchi, PA

Physician Assistant · Venice, FLNPI 1851472187

Payments from drug & device makers

$1,640in general payments, 2019–2025

Across 92 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$727
  • Novartis$264
  • Johnson & Johnson$111
  • Genentech USA, Inc.$98
  • Regeneron Healthcare Solutions, Inc.$92
  • Amgen$89
  • plus $259 from 8 others

What the payments were for

  • Food & beverage$1,640100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,640 in reported general payments places this provider in the 70th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$361,251
Medicare patients
1,307
Services billed
6,458

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast16$116,915
Cosentyx (2 Syringes)Secukinumab12$85,971
Fluorouracil118$8,104
Ketoconazole522$7,074
Betamethasone Dipropionate166$6,978
Fluocinonide167$5,993
CiclopiroxCiclopirox Olamine204$5,501
Clobetasol Propionate65$4,380
Triamcinolone Acetonide304$3,226
Doxycycline Hyclate113$2,575
Metronidazole58$2,554
Mupirocin288$1,912
Ciclopirox55$1,715
Clindamycin Phosphate35$1,128
Levocetirizine Dihydrochloride79$884

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$89$116,91516 claims
NovartisCosentyx (2 Syringes)$264$85,97112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Venice

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →